2024 annual financial data
OptimizeRx 2024 Operating margin
OptimizeRx 2024 operating margin with verified reported values.
Direct answer
Operating margin was -14.88%.
Operating income was -13,706,000 USD and net income was -20,110,000 USD.
Operating cash flow was 4,889,000 USD.
Get free OptimizeRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 92,127,000 USD
- Operating income
- -13,706,000 USD
- Net income
- -20,110,000 USD
- Operating cash flow
- 4,889,000 USD